As an individual struggling with weight loss, you may have already tried numerous diets and exercise programs with limited success. The body's complex systems work to maintain homeostasis and prevent weight change, making sustained weight loss an ongoing challenge. However, new prescription medications are providing promising results for those looking to lose weight and improve their health.
Mounjaro is the latest drug for weight management, working through unique mechanisms to reduce appetite and calorie absorption. Understanding the science behind how Mounjaro induces weight loss can help you determine if it may be right for your needs and set the proper expectations for results.
At M. Zafar, MD, SC, which serves Illinois Statewide by Telehealth, board-certified Dr. Muhammad Zafar can help you improve your health and lose weight with a plan that can include lifestyle modifications, diet, and weight management medication such as Tirzepatide (the Active Ingredient of Mounjaro).
This article will explore how Mounjaro impacts the body's systems to facilitate weight loss and improve metabolic health.
Mounjaro (tirzepatide) is a prescription medication that mimics two natural hormones in your body, GLP-1 and GIP, to suppress appetite and induce weight loss.
GLP-1 and GIP are incretin hormones released in your gut that stimulate insulin secretion and reduce appetite. Mounjaro activates receptors for GLP-1 and GIP which leads to increased insulin release and decreased appetite.
Specifically, Mounjaro stimulates GLP-1 and GIP receptors in the:
In summary, Mounjaro works by mimicking natural hormones in your body to suppress appetite through multiple mechanisms. The end result is reduced hunger, smaller portion sizes, and weight loss over time when used as directed. Continued success requires ongoing lifestyle changes, but Mounjaro can be an effective tool to help you on your journey toward better health.
Mounjaro (tirzepatide) works in two ways to enhance weight loss. First, it mimics the effects of incretin hormones GLP-1 and GIP, which help regulate blood sugar levels and appetite. By activating GLP-1 and GIP receptors, Mounjaro slows digestion and suppresses appetite, reducing feelings of hunger. This makes it easier to cut calories and lose weight.
Second, Mounjaro impacts areas of the brain involved in regulating food intake and body weight. It activates pro-opiomelanocortin (POMC) neurons in the hypothalamus which curb appetite and increase energy expenditure. Simultaneously, it reduces activity in neighboring neurons called Agouti-related peptide (AgRP) neurons which normally stimulate appetite and decrease energy usage. This combined action on critical parts of the brain's appetite center leads to decreased food consumption and increased calorie burning for enhanced weight loss effects.
In summary, Mounjaro works through a two-pronged approach: slowing digestion and reducing appetite to cut calorie intake, while also impacting the brain to regulate food consumption and energy balance in favor of weight loss. By combining these metabolic and neural mechanisms, Mounjaro can produce meaningful weight reduction to improve health and wellness. Patients on Mounjaro in clinical trials lost up to 22.5% of their body weight, demonstrating its efficacy for obesity and weight management when combined with lifestyle changes like diet and exercise.
Mounjaro provides additional benefits beyond weight loss alone. As an incretin mimetic, Mounjaro activates receptors in the body that have wide-ranging effects.
By stimulating insulin secretion and suppressing glucagon release in a glucose-dependent manner, Mounjaro can help lower blood sugar levels in people with type 2 diabetes. Studies show Mounjaro reduces HbA1c, a measure of average blood sugar over 2-3 months, by up to 1.5 percentage points. For some, Mounjaro may be used alone or in combination with other diabetes medications to effectively manage glycemic control.
Excess weight and obesity increase the risk of high blood pressure, abnormal cholesterol levels, and coronary artery disease. By promoting weight loss and improving diabetes control, Mounjaro may help lower cardiovascular risk factors and the chance of heart attack or stroke. Preliminary research indicates Mounjaro could decrease blood pressure, lower LDL or “bad” cholesterol, and raise HDL or “good” cholesterol.
Excess fat accumulation in the liver, known as nonalcoholic fatty liver disease (NAFLD), often accompanies obesity and type 2 diabetes. Studies show Mounjaro may improve liver health by reducing fat deposits in the liver and lowering liver enzyme levels. For some, Mounjaro could help resolve nonalcoholic steatohepatitis (NASH), the more severe form of NAFLD.
In summary, Mounjaro’s ability to stimulate insulin, suppress glucagon, and induce weight loss provides benefits that extend beyond glucose control and weight management alone. By positively impacting cardiovascular and liver health, Mounjaro may help reduce health risks and improve outcomes for overweight and obese individuals with diabetes.
As you have read, Mounjaro is an innovative new medication that can help with long-term weight management and improved health outcomes. By activating receptors in the brain and gut that regulate hunger and fullness, it helps you feel satisfied with smaller portion sizes so you eat less without feeling deprived. The changes in hormones that control blood sugar and fat storage also make it easier for your body to use fat for energy and lose excess pounds. While not a substitute for diet and exercise, Mounjaro provides a scientifically-proven method for overcoming biological obstacles to weight loss and maintenance. By understanding the mechanisms behind how it works, you can feel confident this medication may be the solution to finally achieving and sustaining your weight loss goals.
If you live in Illinois and are ready to enhance your overall health and well-being, schedule a Telehealth appointment with us today to see if you’re a candidate for medical weight loss with Tirzepatide. You can do this by using our online booking tool today.